Today, the U.S. FDA approved the first GLP-1 receptor agonist in a pill for adults with type 2 diabetes. Learn more: http://bit.ly/2msWJyl | Novo Nordisk

Let’s talk about the risks of GLP-1 medications compared to the risks of living with untreated obesity. This isn’t about fear. It’s about facts. GLP-1s can cause side effects like nausea, slowed digestion, and changes in appetite. These are valid concerns. At the same time, obesity increases the risk of stroke, dementia, heart disease, type 2 diabetes, and at least 13 types of cancer. Some people experience a reduction in muscle mass while using a GLP-1, especially without strength training or a

GLP-1/dual incretin agonist side effects (semaglutide / dulaglutide / liraglutide / tirzepatide) “Powerful results, but with precautions. Here are the side effects you should know about GLP-1 and dual incretin agonists 💉 These medications can do wonders — but understanding them keeps you safe and informed. Watch more quick endocrinology insights on this channel!” #GLP1 #IncretinTherapy #PinoyEndocrinologist #DiabetesAwareness #MedTokPH | Doc Ivan Cudal

1.4K views | PART 3- A natural GLP-1 agonist that you can drink every day without the side effects. #glp1 #glp #weightloss #diabetes #fatloss #fyp #naturalremedy #nosideeffects | Paul Minhas | Facebook